StockData
Jaguar Health, Inc. logo

Jaguar Health, Inc. (JAGX) stock

JAGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$0.39−0.03 (-7.14%)

Close on Nov 16, 2026Market cap $2.02MP/E –Yield –

Jaguar Health total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Jaguar Health's total debt was $1.73M at Jun 30, 2026. For fiscal 2025 it was $15.08M, down 35.8% from the year before. The highest annual figure on record is $30.99M in fiscal 2023.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$15.08M-35.8%
FY2024Dec 31, 2024$23.50M-24.2%
FY2023Dec 31, 2023$30.99M+74.7%
FY2022Dec 31, 2022$17.74M-29.1%
FY2021Dec 31, 2021$25.02M+101.4%
FY2020Dec 31, 2020$12.42M+2660.2%
FY2019Dec 31, 2019$450.00K-96.4%
FY2017Dec 31, 2017$12.59M+236.9%
FY2016Dec 31, 2016$3.74M-35.6%
FY2015Dec 31, 2015$5.80M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.73M-83.9%
Q1 FY2026Mar 31, 2026$11.08M-39.9%
Q4 FY2025Dec 31, 2025$15.08M-35.8%
Q3 FY2025Sep 30, 2025$7.65M-64.7%
Q2 FY2025Jun 30, 2025$10.74M-50.8%
Q1 FY2025Mar 31, 2025$18.43M-15.1%
Q4 FY2024Dec 31, 2024$23.50M-24.2%
Q3 FY2024Sep 30, 2024$21.66M-30.5%
Q2 FY2024Jun 30, 2024$21.81M+29.5%
Q1 FY2024Mar 31, 2024$21.72M+23.8%
Q4 FY2023Dec 31, 2023$30.99M+74.7%
Q3 FY2023Sep 30, 2023$31.16M+55.7%
Q2 FY2023Jun 30, 2023$16.85M-27.9%
Q1 FY2023Mar 31, 2023$17.54M-29.2%
Q4 FY2022Dec 31, 2022$17.74M-29.1%
Q3 FY2022Sep 30, 2022$20.01M-19.7%
Q2 FY2022Jun 30, 2022$23.36M-3.5%
Q1 FY2022Mar 31, 2022$24.78M+2.3%
Q4 FY2021Dec 31, 2021$25.02M+101.4%
Q3 FY2021Sep 30, 2021$24.93M+837.1%
Q2 FY2021Jun 30, 2021$24.20M+5948.8%
Q1 FY2021Mar 31, 2021$24.23M+5957.5%
Q4 FY2020Dec 31, 2020$12.42M+2660.2%
Q3 FY2020Sep 30, 2020$2.66M-60.2%
Q2 FY2020Jun 30, 2020$400.00K-94.8%
Q1 FY2020Mar 31, 2020$400.00K–
Q4 FY2019Dec 31, 2019$450.00K-95.8%
Q3 FY2019Sep 30, 2019$6.68M-47.0%
Q2 FY2019Jun 30, 2019$7.76M+330.8%
Q3 FY2018Sep 30, 2018$0-100.0%
Q2 FY2018Jun 30, 2018$10.77M+223.7%
Q4 FY2017Dec 31, 2017$12.59M+236.9%
Q3 FY2017Sep 30, 2017$1.80M-56.3%
Q2 FY2017Jun 30, 2017$2.91M-30.0%
Q1 FY2017Mar 31, 2017$3.33M–
Q4 FY2016Dec 31, 2016$3.74M–
Q3 FY2016Sep 30, 2016$4.12M–
Q2 FY2016Jun 30, 2016$4.15M–

More Jaguar Health figures

See a number that looks wrong?